Associate Director Corporate Counsel - Technology Transactions
Regeneron Pharmaceuticals
Summary
As a member of the Contracts Group in the Regeneron Law Department's Transactions Law Group, the Associate Director, Corporate Counsel will draft, review and negotiate a wide array of contracts for Regeneron's Information Technology & Operations operating teams and provide related advice and counsel. The level of counseling requires a solid understanding of general business transactions and related legal issues, outstanding drafting and negotiation skills and a strong understanding of, or desire to learn about, information technologies, artificial intelligence, and data privacy. The role will have a direct impact on facilitating our science and research.
Job description
When & where
- Location: Sleepy Hollow, NY
- Work model/flexibility: 4 days onsite
Discover your role
- Drafting, negotiating and bringing to execution cloud (SaaS/PaaS/IaaS) and software license agreements, hybrid cloud agreements, and consulting and professional service agreements critical to Regeneron's operations throughout the company.
- Providing legal support and counsel for software applications, data feeds and analytics, infrastructure applications, information security, telecommunications and telephony, and other information technology tools used throughout Regeneron, including for research, development, clinical, manufacturing, commercial, and general administrative services organizations, whether as discrete applications or as an integrated enterprise resource planning platform, often as a licensee of the technology and within a regulated environment.
- Advising on artificial intelligence to the business and interacting with AI Governance.
- Advising on other current and potential legal and commercial issues with industry specific knowledge and transactional guidance.
- Working collaboratively with other groups, including Global Procurement, Digital and Technology Group, Information Security, the Privacy Group, and Risk Management.
- Advising internal clients on Regeneron's contracts policies and practices and applicable laws, and counseling on applicable legal risks and statutes.
- Possess excellent contract drafting and negotiation skills, oral and written communication skills, and strong interpersonal skills.
This role requires
- BA/BS and JD with excellent law school credentials.
- Licensed to practice law in New York or be eligible for licensure as a registered in-house counsel is preferred.
- 4+ years legal experience at a law firm and/or in-house, including strong corporate law experience.
- Possess outstanding oral and written communication skills, including significant presentation capabilities.
- Familiarity with information technology & privacy law and experience negotiating from a licensee position are all pluses.
Requirements
- BA/BS and JD with excellent law school credentials
- Licensed to practice law in New York or eligible for licensure as registered in-house counsel (preferred)
- 4+ years legal experience at a law firm and/or in-house
- Strong corporate law experience
- Outstanding oral and written communication skills
- Significant presentation capabilities
- Familiarity with information technology & privacy law (plus)
- Experience negotiating from a licensee position (plus)
- Excellent contract drafting and negotiation skills
- Strong interpersonal skills
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.